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Abstract
Background
No formal definition for the “complex elderly” exists; moreover, these older patients with
high levels of multi-morbidity are not readily identified as such at point of hospitalisation,
thus missing a valuable opportunity to manage the older patient appropriately within the
hospital setting.
Objectives
To empirically identify the complex elderly patient based on degree of multi-morbidity.
Design
Retrospective observational study using administrative data.
Setting
English hospitals during the financial year 2012–13.
Subjects
All admitted patients aged 65 years and over.
Methods
By using exploratory analysis (correspondence analysis) we identify multi-morbidity groups
based on 20 target conditions whose hospital prevalence was 1%.
Results
We examined a total of 2788900 hospital admissions. Multi-morbidity was highly prevalent,
62.8% had 2 or more of the targeted conditions while 4.7% had six or more. Multi-morbidity
increased with age from 56% (65-69yr age-groups) up to 67% (80-84yr age-group). The
average multi-morbidity was 3.2±1.2 (SD). Correspondence analysis revealed 3 distinct
groups of older patients. Group 1 (multi-morbidity2), associated with cancer and/or
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metastasis; Group 2 (multi-morbidity of 3, 4 or 5), associated with chronic pulmonary dis-
ease, lung disease, rheumatism and osteoporosis; finally Group 3 with the highest level of
multi-morbidity (6) and associated with heart failure, cerebrovascular accident, diabetes,
hypertension and myocardial infarction.
Conclusions
By using widely available hospital administrative data, we propose patients in Groups 2 and
3 to be identified as the complex elderly. Identification of multi-morbidity patterns can help to
predict the needs of the older patient and improve resource provision.
Introduction
Hospital admissions of older patients are in rapid increase and their care management is high
in the agenda of clinicians and policy makers [1]. Between 2002 and 2012, the number of
patients admitted to NHS hospitals in England who were aged 75 and over rose by almost two
thirds [2], furthermore, 65% of people admitted to hospitals were older than 65 years and
accounted for 70% of bed days [3]; as the proportion of people aged 60 and over is increasing
at a faster rate than any other age group [4], demand for hospital care by the oldest patient pop-
ulation will continue to rise [5].
Studies have shown that hospitalised older patients will often present mental, psychological
and/or social difficulties requiring coordinated care from different health specialities [3, 6].
These patients are often referred to as the “complex elderly” or the “older patient with complex
needs” in an attempt to reflect the complexity of care needed by these patients of advanced age
with multiple simultaneous medical conditions [7]. Although the complex elderly label is
deemed inappropriate by some (personal communication, British Geriatrics Society, 2012), it
is a term widely used in medical research and health literature, but so far there is no consensus
on a definition, empirical or otherwise. Past attempts to define the “complex patient” have
incorporated parameters such as the overall cost of care, the need for multiple interventions
(referrals), and/or complexity of clinical profile [8–10]. In the past, the complex elderly term
has been used by health organisations to establish charging costs for this particular group of
patients who are known to consume considerable hospital financial resources. For example, the
Healthcare Resource Group (HRG) algorithm within the English National Health Service
(NHS) tries to group patients consuming similar levels of resources (similar to the Diagnosis-
Related Group system). In this context, HRG (version 3.5, 2007) identified the complex elderly
as those patients having two or more major diagnoses, with no significant procedure recorded
and whose age was greater than 69 years. It is worth mentioning that the HRG grouping for the
complex elderly has not been included in their latest version 4 (HRG4, released Feb 2013), but it
is under review for future releases.
More recently, patient complexity assessment has progressed towards the inclusion of psy-
chological, socioeconomic, cultural, environmental, behavioural as well as biological factors
[11–13]. For this purpose, the Interdisciplinary Medicine Instrument (INTERMED) tool was
introduced to quantify the complexity of care needed by hospitalised patients incorporating
factors such as diagnostics chronicity, mental health, social vulnerability and care coordination
[8, 13].
In contrast, there is an almost universal consensus on the definition of frailty, the state of
vulnerability, which is intrinsic to the aging process [14]. Tools for frailty screening are
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available to clinicians to assess the presumed frail patient on hospital admission [15, 16]. Very
recently, an electronic frailty index (eFI) has been developed to be conveniently obtainable
from universally coded health care records [15].
It is recognised that the state of frailty and complexity are not interchangeable concepts, and
they can coexists as can both exist one without the other [17].While there are processes in
place to identify the frail patient, a gap exists in the identification of the non-frail but complex
hospitalised elderly patient, often presenting high levels of multi-morbidity.
While multi-morbidity in the elderly is highly prevalent, estimates of its prevalence within
the hospital setting are scarce and more so among the elderly [18–21]. Yet, it is well known
that multi-morbidity among the elderly is associated with poor hospital outcomes: decreased
quality of life, psychological distress, longer hospital stays, more postoperative complications,
higher cost of care and higher mortality [22].
As part of a comprehensive assessment at point of admission, an elderly patient may benefit
from a flagging system which identifies a critical level of multi-morbidity to deliver a more
informed care and discharge plan; it is not known, however, at what level of multi-morbidity
an elderly patient is at risk of reaching complexity.
Thus, our objectives are to take advantage of the large number of hospital administrative
records in England in order to:
1. Empirically identify the complex elderly group within the hospital setting based on multi-
morbidity and disease burden indicators
2. Examine whether the so-identified complex elderly show evidence of having significantly
poorer outcomes (readmissions, length of stay, mortality rates) compared with the rest of
the hospital elderly admitted patients.
3. Compare a previously used definition of the complex elderly, with our own empirical
identification
Methods
We used routinely collected hospital administrative data in England, the Hospital Episode Sta-
tistics (HES) dataset. We extracted records for patients admitted in the financial year 2012/13.
Each record in the dataset represents an episode, i.e., a continuous period of care under one
physician. The episodes are linked to spells (continuous period of care in one hospital) and to
superspells (spells in other hospitals due to transfers). We extracted finished inpatient episodes
for patients aged at least 65 years and excluded transfers to/from other hospitals. All patient
records were anonymized prior to analysis.
We defined multi-morbidity as the simultaneous presence of at least 2 conditions from a list
of 20 major conditions including chronic illnesses (Table A in S1 File). This list comprised
conditions with a prevalence of at least 1% and defined in the Charlson and Elixhauser sets of
comorbidity groups [23–25], which assigns ICD-10 clinical diagnoses codes to each medical
condition. For descriptive statistics, categorical variables (i.e. gender, age groups, diagnoses
codes, deaths, and readmissions) were described in terms of counts/frequencies; for quantita-
tive variables (Charlson comorbidity score, length of stay), means and standard deviations
were calculated. For reporting outcome measures, we counted emergency admissions and read-
missions within 28 days and calculated mean length of stay and in-hospital 30-day mortality
rates. A p value of less than 0.05 was considered to be significant.
Correspondence Analysis (CA) was used to identify associations between multi-morbidity
and medical conditions. See Section A in S1 File for details on this Methodology.
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For further analysis, the HRG grouping was also dichotomised (present or absent) to indi-
cate whether a patient (record) is considered to be a complex elderly under the HRG definition.
We calculated the burden of disease, or co-morbidity burden, by taking each targeted condition
and calculating the proportion of patients having the condition at each level of multi-
morbidity.
We used SAS software version 9.2 to carry out all statistical analysis. We used the PROC
CORRESP procedure to carry out the correspondence analysis.
Results
Our sample consisted of a total of 2788900 hospital admissions. 52.8% were females (mean
age±SD of 77.5±8.3 years) and the rest were males (mean age±SD of 76.0±7.5 years) (Table 1).
62.8% had 2 or more conditions from our list, while 4.7% had 6 or more (Table 1 and Fig 1A).
The overall average morbidity (at least 1 medical condition from target list) in our sample was
2.7±1.5, and the average multi-morbidity (at least 2 coexisting medical conditions) was 3.2±1.2.
Multi-morbidity rose up to the age of 80, declining thereafter (Fig 1B). The proportion of
female to male patients with 2 or more coexisting medical conditions increased steadily with
age, with more than two thirds being female patients aged 90 and over (Fig 1C).
We found that certain medical conditions were highly prevalent in the elder hospital popu-
lation; Fig A in S1 File shows the prevalence of our list of medical conditions. Over 45% of all
Table 1. Sample characteristics.
Characteristic Total (%) Total 2 788 900 (100) Male1 315 518 (47.2) Female 1 473 382 (52.8)
Age Group (years) Number of admissions (%)
(65–69) 505 580 (18.2) 271 016 (53.6) 234 564 (46.4)
(70–74) 497 684 (17.8) 261 535 (52.6) 236 149 (47.4)
(75–79) 539 742 (19.4) 273 924 (50.8) 265 818 (49.2)
(80–84) 532 789 (19.1) 246 145 (46.2) 286 644 (53.8)
(85–89) 421 689 (15.1) 171 197 (40.6) 250 492 (59.4)
90 and over 291 416 (10.4) 91 701 (31.5) 199 715 (68.5)
Comorbidity score*
0 1 111 077 (39.8) 486 783 (43.8) 624 294 (56.2)
1–3 193 938 (7.0) 98 618 (50.9) 95 320 (49.1)
4–5 335 919 (12.0) 155 281 (46.2) 180 638 (53.8)
6 and over 1 147 966 (41.2) 574 836 (50.1) 573 130 (49.9)
Multi-morbidity1
0 418 274 (15.0) 188 387 (45.0) 229 887 (55.0)
1 619 265 (22.2) 281 797 (45.5) 337 468 (54.5)
2 639 626 (22.9) 302 619 (47.3) 337 007 (52.7)
3 493 287 (17.7) 237 539 (48.2) 255 748 (51.8)
4 315 133 (11.3) 153 801 (48.8) 161 332 (51.2)
5 171 623 (6.2) 84 743 (49.4) 86 800 (50.6)
6+ 131 692 (4.7) 66 632 (50.6) 65 060 (49.4)
2+ 1 751 361 (62.8) 845 334 (48.3) 906 027 (51.7)
3+ 1 111 735 (39.9) 542 715 (48.8) 569 020 (51.2)
*comorbidity score using the Charlson index and derived from secondary diagnosis ﬁelds and speciﬁc to
English data.
1 Count of comorbidities listed in Table A in S1 File
doi:10.1371/journal.pone.0145372.t001
Who Are the Complex Elderly?
PLOS ONE | DOI:10.1371/journal.pone.0145372 December 30, 2015 4 / 11
admitted older patients had hypertension, about 20% had lung conditions, closely followed by
myocardial infarction and diabetes (with complications) at 19%, and 13% had some form of
cancer (malignant neoplasm).
Table B in S1 File presents outcome measures by age-group and multi-morbidity level. As
expected, increase age and level of multi-morbidity were positively correlated with poorer
outcomes.
Correspondence Analysis
Fig 2 is a visual representation of the relationship between each medical condition and multi-
morbidity with the added information on age group. See Section B in S1 File for a detailed
explanation of this plot.
We identify the following:
Group 1.On the positive side of dimension one; we have older patients with multi-morbid-
ity of 1 and 2 associated with conditions such as dementia, cancer, hypertension and neurologi-
cal conditions.
Group 2. Contributing to dimension 2, we find patients with multi-morbidity of 3 and asso-
ciated with conditions such as malignant neoplasms, diabetes (without complications) and
cerebrovascular disease.
Group 3. In opposition, on the negative side of dimension 1, we find patients with higher
multi-morbidity levels (4, 5 and 6+) strongly associated with heart failure (including congestive
heart failure), lung conditions (incl. asthma and chronic pulmonary diseases), rheumatoid
arthritis, and connective tissue disorders (incl. arthritis). Categories located near the centroid
of the diagram have average distributions and contribute weakly to either dimension; these
include myocardial infarction, gastric ulcers, drug abuse among others (<1%).
Fig 1. A) Distribution of multi-morbidity in hospitalised elderly patients B) Multi-morbidity by age
group C) Gender prevalence by age for patients with multi-morbidity of 2+.
doi:10.1371/journal.pone.0145372.g001
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Group 1 made up 45.1% of our sample. Over 33% of patients in this group had hypertension
recorded, 10% had cancer and 7% with dementia. Group 2 of medium multi-morbidity com-
prised those having multi-morbidity of 3 and making 17.7% of the sample. In this group, 25%
had diabetes (without complications), 10% with cerebrovascular disease (stroke) and 6% with
malignant melanoma. Finally, Group 3 with the highest multi-morbidity (4, 5, 6+), which is
placed in strong contrast to Group 1, makes 22.2% of our sample. Over 64% of patients in this
group had heart failure (including congestive heart failure), 54% with lung conditions (incl.
asthma and chronic pulmonary diseases), 10% with connective tissue disorders and 11% with
rheumatoid arthritis.
Table C in S1 File compares outcomes for the multi-morbid groups and for the ‘healthy’
elderly, Group 0, those elderly patients in our sample who were admitted to hospital but pres-
ent none of our list of medical conditions (but may have been diagnosed with other non-major
or non-chronic conditions). When comparing these, we observe significant differences
(p<0.0001) among the four groups. Performing Tukey’s HSD test reveals that Groups 2 and 3
have the smallest significant differences between them but the largest compared with Groups 1
and 0; furthermore, Groups 2 and 3 present the worse outcomes. The proportion of emergency
admissions for Groups 2 and 3 is 20% and 26% higher respectively compared with Group 0.
The mean length-of-stay is also longer; patients in Group 2 have lengths of stay 45% longer
compared with Group 0, increasing to 60% longer for patients in Group 3. Mortality followed a
similar pattern. Readmission rates are 1.4 and 1.7 times higher in Groups 2 and 3 respectively
compared with Group 0. Thus, based on multi-morbidity level, we identify 2 groups of patients
Fig 2. Bi-plot for multi-morbidity level and targetedmedical conditions. Group 1 (dashed line); Group 2 (thick line); Group 3 (thin line).Dot-dashed
line corresponds to average profiles. Blue dots represent the position of medical conditions on the bi-plot. Red dots represent multi-morbidity levels and
green triangles represent the age groups as supplementary variables.
doi:10.1371/journal.pone.0145372.g002
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(Groups 2 and 3) within the elderly hospital population who are at greater risk of having
adverse outcomes and could be identified as the complex elderly.
The association between age and medical conditions shows that the hospitalised elderly
patients within the 65–69, 70–74 and 75–79 age groups tend to have medical conditions such
malignant melanomas, diabetes (without complications), cerebrovascular diseases and lung
conditions (including asthma and chronic pulmonary diseases). The eldest elderly in the age
groups 80 and above are more likely to have conditions such as dementia, obesity, depression,
heart failure (including congestive heart failure), peripheral vascular disease and neurological
diseases.
Co-morbidity Burden
Co-morbidity burden is defined as the proportion of patients with an index medical condition
having 1 or more conditions from our target list. Table D in S1 File presents the co-morbidity
burden for all listed conditions per number of co-morbidities. Some conditions such as hyper-
tension, cancer, and dementia have a low co-morbidity burden, others such as heart failure
(incl. chronic), rheumatoid arthritis, connective tissue disorders present higher burden; a larger
number of medical conditions present an intermediate burden.
Table E in S1 File presents the main clinical outcomes for the identified complex elderly
(Groups 2 and 3) and for the complex elderly identified under the HRG definition used in the
past. The HRG group is comprised of a smaller proportion of patients compared to our own.
We also include the non-complex elderly from our study, those elderly patients in Groups 0
and 1. We observe significant differences between these 3 groupings.
Discussion
Our study shows that 22.2% of the elderly hospital population has been diagnosed with one
major medical condition, whereas a substantial larger proportion, 62.8%, have 2 or more.
Based on the association of multi-morbidity level and medical conditions, we have identified 3
distinct groups of elderly patients in English hospitals. Group 1 is made up of elderly patients
with low multi-morbidity and associated with medical conditions having low disease burden;
this Group also shows the best outcomes. Group 2 is characterised by patients with medium
multi-morbidity and conditions of medium disease burden. Finally, Group 3 is made up of
patients with the highest multi-morbidity (3+) and having medical conditions with the highest
disease burden; this group shows the worse outcomes.
The complex elderly label has been used rather loosely in the past and has lacked a consistent
definition; thus, to fulfil our first objectives, we propose an empirical prescription for their
identification in the hospital setting as those patients within Groups 2 and 3, i.e., hospitalised
patients,65 years old, who have at least 3 simultaneous diagnoses of major clinical conditions.
Second, examination of this Group, shows that the complex elderly thus identified account for
39.9% of our sample, or 1111735 admissions in a single year and show significant (p<0.0001)
worse clinical outcomes than the non-complex older patient cohort (Groups 0 and 1, Table E
in S1 File). This proposed definition could be used as part of routinely collected administrative
data for hospital resource planning, health service research and risk stratification. Once the def-
inition for the complex elderly in the hospital setting is in place, it could be used to determine
and compare outcomes across institutions as an indicator of quality of care. Furthermore, as it
is believed that hospital resource utilisation is overall higher for elderly compared with young
patients [26], it is imperative to clearly identify those complex elderly patients who will poten-
tially require substantial more resources.
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With regards to our third objective, we note that outcome indicators for the HRG complex
elderly group are significantly different (p<0.0001) from those from our proposed definition
(Table E in S1 File).This is not a concern. The HRG definition was based on a higher age
threshold (at least 69 years.) of patients with at least 2 conditions from a specific list of clinical
diagnoses and thus it focused on a smaller cohort of high-risk patients. All those patients con-
sidered complex elderly under the HRG definition made up a total of 11.6% (323 396) of the
total sample. Fig 3 illustrates the overlap between both definitions for the complex elderly; our
definition captures 76.7% of the HRG complex elderly patients. Our complex elderly definition
captures a larger elderly population, almost 3.5 times the one defined by HRG, and therefore,
the previously used HRG grouping could have significantly underestimated the real cost of car-
ing for the complex elderly within the hospital setting.
By using different approaches, a number of studies have focused on the subject of multi-
and co-morbidity. However, data sources vary significantly, and it is difficult to make direct
comparisons; nevertheless, there are encouraging common results. For example, we find some
agreement with a study that uses GP medical records of patients in a small European commu-
nity [27]; they find patterns of co-morbidity according to age; older patients (70 years and
above) were clustered around diseases such as cardiac arrhythmias, hypertension, diabetes
(with and without complications), heart diseases, cerebrovascular disease, renal failure and
congestive heart failure. A high disease burden was found for conditions such as heart failure,
cerebrovascular disease, and renal failure among others. Another study which focused on the
elderly aged 65 years and over used insurance companies record [28] to find 3 patterns of
multi-morbidity in the elderly (cardiovascular/metabolic, anxiety/depression/somatoform and
pain, and neuropsychiatric disorders); these patterns, however, were not related to specific age
subgroups.
Using a general population sample of subjects aged 65–95 years, it has been shown that the
effect of social support on mortality increases in subjects with the highest comorbidity; more-
over, social support is predictive of long-term mortality in the elderly [29].Within the hospital
setting however, it is not known to what degree social support is predictive of elderly mortality
(see Limitations).
Limitations
One of the limitations of the present study is the use of administrative data sets. Our results
depend highly on the recorded clinical diagnoses, and debate exists as to the accuracy of clinical
coding within HES [30]; thus to minimise this effect we have used the latest available HES data
(2012–2013), as we know accuracy in coding practice has greatly improved over the last years.
Fig 3. Venn diagram illustrating the overlap between the HRG definition and our proposed definition
for complex elderly patients.
doi:10.1371/journal.pone.0145372.g003
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Furthermore, hospitals perform limited validation against other databases, and no systematic
chart abstraction exists. However, in England, levels of reported accuracy suggest that routinely
collected administrative data are sufficiently robust to support their use in research [30–32].
Another limitation concerns the selection of medical conditions included in our analysis; at
present, there in no standard list of major or chronic diseases, and thus the listed conditions
might not be extensive, but we have tried to include all major chronic diseases which are
already defined in terms of common comorbidities indices (Charlson and Elixhauser). Refine-
ments could be made regarding the inclusion of other medical conditions. Definitions of Charl-
son and Elixhauser comorbidities are available for ICD9. An analysis by gender could also
prove useful in providing further clues to improve the care of the oldest patients. Due to lack of
information regarding social support within hospital administrative data, we are unable to fur-
ther investigate the relationship between social support, multi-morbidity and long term mor-
tality in hospitalised elderly patients.
Conclusions
Our study has been based on administrative records from English hospitals but could easily be
applied to other healthcare systems where administrative data are routinely gathered. We have
identified 3 Groups of older patients who present significant different outcomes and clinical
profiles. Based on our findings, we propose an easily replicable approach to identify the com-
plex elderly in the acute hospital setting, as those admitted patients, aged 65 years and older
with 3 or more co-existing diagnoses from a target list of medical conditions (Groups 2 and 3).
These patients present with high disease burden and are commonly diagnosed with heart fail-
ure (including chronic), rheumatoid arthritis, connective tissue disorders, pulmonary disease
and diabetes.
For the purposes of administrative hospital costs, it would be desirable to re-evaluate and
re-introduce a complex elderly definition; to this effect we provide a method and justification.
Given the trend of increasing admissions of elderly patients to hospitals, there is great demand
for a more cost-effective care of hospitalised patients, particularly of those who consume a sub-
stantial amount of resources. A revised complex elderly definition would not only benefit the
patient themselves, but all those involved in their management and care.
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